HTG Molecular Diagnostics Inc (STU:65H)
€ 0.242 0 (0%) Market Cap: 1,000.00 Enterprise Value: -2.44 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q2 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript

Aug 06, 2019 / 08:30PM GMT
Release Date Price: €209.88 (+1.99%)
Operator

Good afternoon and welcome to HTG Molecular Diagnostics Second Quarter Earnings Conference Call. My name is Amy, and I will be your coordinator for the call today. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.

I would now like to turn it over to Monique Kosse from LifeSci Advisors for a few introductory remarks.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, Amy. Earlier today, HTG released financial results for the quarter ended June 30, 2019.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal security laws, including statements regarding possible additional collaborations with pharma customers, anticipated continued growth in RUO profiling business and related revenues, expected growth in benefits from biopharma programs and collaborations, product development and commercialization activities and revenue expectations for the full year 2019. These forward-looking statements are subject to numerous risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot